# Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso

> **NCT03682653** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 21832 (actual)

## Conditions studied

- Childhood Mortality

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03682653
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-11
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 21832 (ACTUAL)
- **Last updated:** 2023-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682653, "Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03682653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*